The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the biopharmaceutical industry operating in Europe.
Disclosure of Payments
Collaboration between pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) benefits patients. It is a relationship that has delivered new vaccines and medicines and fosters the innovation that improves patients' lives. Furthermore, patient organisations (POs) play a critical role in Europe's healthcare: from prevention and awareness, through research and development, regulatory and HTA decision-making, to service design and outcomes measurement.
Bringing greater transparency to this already well-regulated and vital relationship, builds understanding of industry-POs and HCPs/HCOs collaboration and, in the context of increasing societal expectations on transparency, addresses directly public concerns about interactions between the medical community and the pharmaceutical industry.
European Disclosure Gateway
As part of its support for greater transparency, the pharmaceutical industry has voluntarily created a single point of access to help any interested stakeholder navigate the publicly available data on details of payments and other benefits in kind made by the industry to HCPs and HCOs across all EFPIA Members countries.
Navigate the European Gateway map by clicking on the 'European disclosure gateway' link.